Obsah souboru
<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Publisher PUBLIC "-//MetaPress//DTD MetaPress 2.0//EN" "http://public.metapress.com/dtd/MPRESS/MetaPressv2.dtd">
<Publisher>
<PublisherInfo>
<PublisherName>University of South Bohemia, Ceske Budejovice and Versita, Warsaw</PublisherName>
</PublisherInfo>
<Journal>
<JournalInfo JournalType="Journals">
<JournalPrintISSN>1214-021X</JournalPrintISSN>
<JournalElectronicISSN>1214-0287</JournalElectronicISSN>
<JournalTitle>Journal of Applied Biomedicine</JournalTitle>
<JournalCode>JAB</JournalCode>
<JournalID>121649</JournalID>
<JournalURL>http://versita.metapress.com/link.asp?target=journal&id=121649</JournalURL>
</JournalInfo>
<Volume>
<VolumeInfo>
<VolumeNumber>8</VolumeNumber>
</VolumeInfo>
<Issue>
<IssueInfo IssueType="Regular">
<IssueNumberBegin>3</IssueNumberBegin>
<IssueNumberEnd>3</IssueNumberEnd>
<IssueSupplement>0</IssueSupplement>
<IssuePartStart>0</IssuePartStart>
<IssuePartEnd>0</IssuePartEnd>
<IssueSequence>000008000320100901</IssueSequence>
<IssuePublicationDate>
<CoverDate Year="2010" Month="9" Day="1"/>
<CoverDisplay>Number 3 / September 2010</CoverDisplay>
</IssuePublicationDate>
<IssueID>W7U4305X5R35</IssueID>
<IssueURL>http://versita.metapress.com/link.asp?target=issue&id=W7U4305X5R35</IssueURL>
</IssueInfo>
<Article ArticleType="Original">
<ArticleInfo Free="No" ESM="No">
<ArticleDOI>10.2478/v10136-009-0019-3</ArticleDOI>
<ArticlePII>612887H7X1W59254</ArticlePII>
<ArticleSequenceNumber>5</ArticleSequenceNumber>
<ArticleTitle Language="En">Membrane-active peptides as anti-infectious agents</ArticleTitle>
<ArticleFirstPage>159</ArticleFirstPage>
<ArticleLastPage>167</ArticleLastPage>
<ArticleHistory>
<RegistrationDate>20100708</RegistrationDate>
<ReceivedDate>20100708</ReceivedDate>
<Accepted>20100708</Accepted>
<OnlineDate>20100708</OnlineDate>
</ArticleHistory>
<FullTextFileName>612887H7X1W59254.pdf</FullTextFileName>
<FullTextURL>http://versita.metapress.com/link.asp?target=contribution&id=612887H7X1W59254</FullTextURL>
<Composite>3</Composite>
</ArticleInfo>
<ArticleHeader>
<AuthorGroup>
<Author AffiliationID="A1">
<GivenName>Luis</GivenName>
<Initials/>
<FamilyName>Rivas</FamilyName>
<Degrees/>
<Roles/>
</Author>
<Author AffiliationID="A1">
<GivenName>Juan</GivenName>
<Initials>Román</Initials>
<FamilyName>Luque-Ortega</FamilyName>
<Degrees/>
<Roles/>
</Author>
<Author AffiliationID="A1">
<GivenName>María</GivenName>
<Initials/>
<FamilyName>Fernández-Reyes</FamilyName>
<Degrees/>
<Roles/>
</Author>
<Author AffiliationID="A2">
<GivenName>David</GivenName>
<Initials/>
<FamilyName>Andreu</FamilyName>
<Degrees/>
<Roles/>
</Author>
<Affiliation AFFID="A1">
<OrgDivision/>
<OrgName>Department of Physico Chemical Biology CSIC, Centro de Investigaciones Biológicas — CSIC, Madrid, Spain</OrgName>
<OrgAddress/>
</Affiliation>
<Affiliation AFFID="A2">
<OrgDivision/>
<OrgName>Department of Experimental and Health Sciences, Barcelona Biomedical Research Park, Universitat Pompeu Fabra, Barcelona, Spain</OrgName>
<OrgAddress/>
</Affiliation>
</AuthorGroup>
<Abstract Language="En">The lipid components of pathogen cell membranes have been considered as a poor pharmacological target, due to their universal distribution and apparent homogeneity throughout living organisms. Among the rare exceptions to this view one could mention polyene antibiotics such as amphotericin, or peptide antibiotics such as the polymyxins and the gramicidins. In the last two decades, however, the above notion has been challenged by two main lines of discovery; first, natural antimicrobial peptides (AMPs) that kill pathogens by interaction with phospholipids and membrane permeabilization, and secondly, cell-penetrating peptides (CPPs), capable of introducing into cells a variety of cargoes in the absence of specific receptors, again by interaction at some point with membrane phospholipids. For both AMPs and CPPs, the pharmacological proof-of-concept has been successfully demonstrated, and promising applications as nanobiotechnological tools have been envisaged though not hitherto materialized in clinical settings. In this review we briefly examine the pros and cons of these two classes of therapeutic agents, as well as strategies aimed at rationalizing and expanding their potentiality.</Abstract>
<KeywordGroup Language="En">
<Keyword>membrane</Keyword>
</KeywordGroup>
<KeywordGroup Language="En">
<Keyword>cell-penetrating peptide</Keyword>
</KeywordGroup>
<KeywordGroup Language="En">
<Keyword>antimicrobial peptide</Keyword>
</KeywordGroup>
<KeywordGroup Language="En">
<Keyword>antibiotic resistance</Keyword>
</KeywordGroup>
<KeywordGroup Language="En">
<Keyword>infectious disease</Keyword>
</KeywordGroup>
<biblist>
<bib-other>
<bibtext seqNum="1"> Alves ID, Jiao CY, Aubry S, Aussedat B, Burlina F, Chassaing G, Sagan S: Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. Biochim Biophys Acta, 2010, doi:10.1016/j.bbamem.2010.02.009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="2"> Brogden KA, Ackermann M, Huttner KM: Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect Immun 66:5948-5954, 1998.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="3"> Carretero M, Del Rio M, Garcia M, Escamez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F: A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18:1931-1933, 2004.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="4"> Christensen B, Fink J, Merrifield RB, Mauzerall D: Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Nat Acad Sci USA 85:5072-5076, 1988.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="5"> Dawson RM, Liu CQ: Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit Rev Microbiol 34:89-107, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="6"> Hopkins KL, Davies RH, Threlfall EJ: Mechanisms of quinolone resistance in <i>Escherichia coli</i> and <i>Salmonella:</i> recent developments. Int J Antimicrob Agents 25:358-373, 2005.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="7"> Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M: Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nature Immunol 5:836-843, 2004.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="8"> Jerala R, Porro M: Endotoxin neutralizing peptides. Curr Top Med Chem 4:1173-1184, 2004.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="9"> Koczan G, Ghose AC, Mookerjee A, Hudecz F: Methotrexate conjugate with branched polypeptide influences <i>Leishmania donovani</i> infection <i>in vitro</i> and in experimental animals. Bioconjug Chem 13:518-524, 2002.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="10"> Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME: Interaction of human defensins with <i>Escherichia coli.</i> Mechanism of bactericidal activity. J Clin Invest 84:553-561, 1989.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="11"> Lemaitre B, Hoffmann J: The host defense of <i>Drosophila melanogaster.</i> Annu Rev Immunol 25:697-743, 2007.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="12"> Lupetti A, Welling MM, Pauwels EK, Nibbering PH: Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 3:223-229, 2003.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="13"> Luque-Ortega JR, van't Hof W, Veerman EC, Saugar JM, Rivas L: Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in <i>Leishmania.</i> FASEB J 22:1817-1828, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="14"> Marcos JF, Muñoz A, Pérez-Payá E, Misra S, López-García B: Identification and rational design of novel antimicrobial peptides for plant protection. Annu Rev Phytopathol 46:273-301, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="15"> Matsuzaki K: Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788:1687-1692, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="16"> Melo MN, Ferre R, Castanho MA: Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7:245-250, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="17"> Metz-Boutigue MH, Shooshtarizadeh P, Prevost G, Haikel Y, Chich JF: Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules. Curr Pharm Des 16:1024-1039, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="18"> Mitev GM, Mellbye BL, Iversen PL, Geller BL: Inhibition of intracellular growth of <i>Salmonella enterica</i> serovar <i>Typhimurium</i> in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer. Antimicrob Agents Chemother 53:3700-3704, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="19"> Mogi T, Kita K: Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol Life Sci 66:3821-3826, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="20"> Niyonsaba F, Nagaoka I, Ogawa H, Okumura K: Multifunctional antimicrobial proteins and peptides: natural activators of immune systems. Curr Pharm Des 15:2393-2413, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="21"> Otte JM, Zdebik AE, Brand S, Chromik AM, Strauss S, Schmitz F, Steinstraesser L, Schmidt WE: Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 156:104-117, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="22"> Otto M: Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol 306:251-258, 2006.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="23"> Otto M: Bacterial sensing of antimicrobial peptides. Contrib Microbiol 16:136-149, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="24"> Otvos L, Jr.: Antibacterial peptides and proteins with multiple cellular targets. J Pept Sci 11:697-706, 2005.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="25"> Peschel A: How do bacteria resist human antimicrobial peptides? Trends Microbiol 10:179-186, 2002.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="26"> Powers JP, Tan A, Ramamoorthy A, Hancock REW: Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry 44:15504-15513, 2005.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="27"> Rao KS, Ghorpade A, Labhasetwar V: Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 6:771-784, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="28"> Rodríguez-Hernández MJ, Saugar JM, Docobo-Pérez F, de la Torre BG, Pachón-Ibáñez ME, García-Curiel A, Fernández-Cuenca F, Andreu D, Rivas L, Pachón J: Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of <i>Acinetobacter baumannii.</i> J Antimicrob Chemother 58:95-100, 2006.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="29"> Rosenfeld Y, Shai Y: Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758:1513-1522, 2006.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="30"> Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G, Mericle RA: Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem Commun (Camb) 25:3144-3146, 2005.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="31"> Schittek B, Paulmann M, Senyurek I, Steffen H: The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8:135-143, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="32"> Selsted ME: θ-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated α-defensins. Curr Protein Pept Sci 5:365-371, 2004.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="33"> Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau HU, Jacobsen F, Al-Benna S: Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci 10:3951-3970, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="34"> Sun X, Salih E, Oppenheim FG, Helmerhorst EJ: Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties. FASEB J 23:2691-2701, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="35"> Torchilin VP: Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90:604-610, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="36"> Vives E, Schmidt J, Pelegrin A: Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786:126-138, 2008.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="37"> Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, Merrifield RB: All-D amino acid-containing channel-forming antibiotic peptides. Proc Nat Acad Sci USA 87:4761-4765, 1990.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="38"> Watkins CL, Brennan P, Fegan C, Takayama K, Nakase I, Futaki S, Jones AT: Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Control Release 140:237-244, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="39"> Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, Oppenheim JJ, Lubkowski J, Lu W: Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Nat Acad Sci USA 100:8880-8885, 2003.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="40"> Yang D, de la Rosa G, Tewary P, Oppenheim JJ: Alarmins link neutrophils and dendritic cells. Trends Immunol 30:531-537, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="41"> Zasloff M: Antimicrobial RNases of human skin. J Invest Dermatol 129:2091-2093, 2009.</bibtext>
</bib-other>
<bib-other>
<bibtext seqNum="42"> Zhang L, Falla TJ: Host defense peptides for use as potential therapeutics. Curr Opin Investig Drugs 10:164-171, 2009.</bibtext>
</bib-other>
</biblist>
</ArticleHeader>
</Article>
</Issue>
</Volume>
</Journal>
</Publisher>
rivas.xml